Vial, a global tech-driven CRO providing next-generation clinical trial management services, has partnered with MLM Medical Labs (“MLM”), an international central and specialty laboratory with locations in Europe and North America. MLM will provide Vial with central laboratory solutions, including study setup management, sample analysis, proprietary MLM Kit Building – which includes customized, all-in-one sample collections kits, tracking bar-codes, and color-coded labeling solutions – and more.
MLM also provides a complete sample management solution and a real-time, secured clinical data portal through its proprietary MLM Sample Storage System® and MLM-Online. For clients needing point of collection sample tracking, MLM has partnered with TruLab, Inc. to provide biopharma and CROs with the precise location of samples from the collection site, real-time monitoring of protocol deviations, informed consent tracking, and reconciliation of specimen data. This highly integrated technology suite provides valuable resources to trial sponsors and CROs as well as to site staff, CRAs, medical monitors, and project managers.
“We’re thrilled to partner with the MLM team who will help us provide our sponsors with the utmost quality and efficient central laboratory solutions. MLM’s products help eradicate paper-based workflows, which eases the burdens of data entry and other monotonous tasks for site staff,” said Simon Burns, CEO and Co-Founder of Vial.
Vial promises to deliver faster, more efficient trials for biotech sponsors at an affordable rate. The Vial CRO distinguishes itself by leveraging digital technology, such as its technology platform, TrialOS, combining eSource, EDC, and ePRO in one connected system to streamline site processes. Vial EDC is a modern, intuitive, and hyper-responsive EDC platform delivering a consumer-grade experience and next-generation performance to eClinical software. These best-in-class CRO services, combined with top vendor partnerships like MLM, help accelerate the development of new therapies and devices for sponsors and patients.
“MLM is excited to join Vial in this integrated partnership. We look forward to helping Vial deliver faster, more efficient trials for biopharma sponsors. Alliances such as this allow partners to work smarter, combining unique expertise in clinical research with leading edge information technology that allows investigators and staff to focus on subjects – reducing queries and costly errors and ultimately saving time and valuable resources,” said MLM CEO, Scott Houlton.
SOURCE: Prnewswire